| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 365.1MM | +18% |
| Operating Income | 24.6MM | -218% |
| Operating Expenses | 340.4MM | - |
| Net Income | 45.7MM | -212% |
| R&D | 195.5MM | +1% |
| G&A | 131.7MM | +9% |
| Amortization | 763K | +74% |
| Interest Expense | 5.2MM | +0% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
In this article, we discuss the 10 unstoppable stocks that will make you richer. To skip the detailed analysis of the economy and market, go directly to the 5 Unstoppable Stocks That Will Make You Richer. On April 12, the week closed out with stocks tumbling as the S&P 500 recorded its worst day since […]
Sarepta will likely miss first-quarter expectations, an analyst said Monday, noting Sarepta stock has taken a beating since its last report.
These drugmakers have made important moves over the past year.
Michael Taylor runs the Simplify Health Care ETF, which donates its management fees to Susan G. Komen for the Cure to fund breast-cancer research and help people with the disease.
CAMBRIDGE, Mass., March 29, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2024 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 8 individuals hired by Sarepta in March 2024. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...
One of the leaders in the global DMD drugs market is expected to outperform
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
In this article, we will take a detailed look at Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Ken Fisher and Corporate Insiders Are Buying These 5 Stocks. Stocks wobbled on Thursday after a hotter-than-expected PPI report confirmed fears that inflation […]